Fig. 1From: The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinomaThe flow chart demonstrates the patient selectin on this study. During the period from December 2007 to December 2012, 385 consecutive esophageal cancer patients underwent a surgical resection at our institution. The patients with other histopathological finding without SCC were excluded because SCC is the predominant histologic type of esophageal cancer, accounting for approx. 90% of all cases; non-SCC patients are rare. SCC: squamous cell carcinoma, NAC: neoadjuvant chemotherapy, NACRT: neoadjuvant chemoradiotherapy, ESCC: esophageal squamous cell carcinomaBack to article page